Konczalla Juergen, Vatter Hartmut, Weidauer Stefan, Raabe Andreas, Seifert Volker
Department of Neurosurgery, Institute of Neuroradiology, Johann Wolfgang Goethe-University, D-60528 Frankfurt am Main, Germany.
Exp Biol Med (Maywood). 2006 Jun;231(6):1064-8.
The substantial role of endothelin-1 (ET-1) in the development of cerebral vasospasm (CVS) after subarachnoidal hemorrhage (SAH) has been demonstrated by numerous experimental and, recently, clinical investigations. Whether the expression or function of the ET(B) receptor is altered in CVS is still unclear, however. The aim of the present study was, therefore, to characterize the cerebroarterial ET(B) receptor function during CVS. Experimental CVS was induced by the rat double-hemorrhage model. Reduction of the cerebral blood flow (CBF) was confirmed by magnetic resonance perfusion-weighted imaging. Animals were sacrificed on days 3 (d3) and 5 (d5) after CVS induction. The basilar arteries (BA) were dissected, cut into ring segments, and prepared for measurement of isometric force in an organ bath. Concentration-effect curves (CECs) were constructed by cumulative application of ET-1, acetylcholine (Ach), or sarafotoxin S6c (S6c). Segments with (E+) endothelial function were used. CECs were compared by the maximum effect (E(max)), the pD2, and the shift calculated on the pD2 level. The pD2 is the negative decadic logarithm of the concentration producing the half maximal effect (-log10EC50). After SAH, the relative regional CBF in the d3 and d5 groups was reduced to 63% and 32%, respectively, of the CBF in controls. ET-1 induced a dose-dependent contraction of segments with and segments without CVS. In E+ segments, the E(max) for ET-1 was not significantly changed after SAH (mean values [ +/- SEM] of 104% +/- 4% for the control group, 106% +/- 4% for the d3 group, and 104% +/- 3% for the d5 group). The CECs, however, were significantly shifted to the left versus the control by factors of 2.4 in the d3 group and 3.6 in the d5 group. Relaxation by S6c was significantly reduced after SAH (E(max:) 73% +/- 11% in the control group, 21% +/- 13% in the d3 group, and 13% +/- 8% in the d5 group), whereas relaxation associated with Ach was not significantly changed (E(max): 45% +/- 7% in the control group, 56% +/- 6% in the d3 group, and 43% +/- 6% in the d5 group). Significant contraction by S6c was not observed in E+ and E - segments in any of the study groups. The present data indicate the loss of the ET(B) receptor-mediated relaxation of the cerebral arteries in cases of CVS, which is independent of the endothelial nitric oxide synthase level.
大量实验以及最近的临床研究均已证实内皮素 -1(ET -1)在蛛网膜下腔出血(SAH)后脑血管痉挛(CVS)的发生发展中起重要作用。然而,ET(B)受体的表达或功能在CVS中是否改变仍不清楚。因此,本研究的目的是明确CVS期间脑动脉ET(B)受体的功能。通过大鼠双次出血模型诱导实验性CVS。采用磁共振灌注加权成像确认脑血流量(CBF)降低。在诱导CVS后第3天(d3)和第5天(d5)处死动物。解剖基底动脉(BA),切成环形节段,制备用于在器官浴中测量等长力。通过累积应用ET -1、乙酰胆碱(Ach)或沙拉毒素S6c(S6c)构建浓度 -效应曲线(CEC)。使用具有(E +)内皮功能的节段。通过最大效应(E(max))、pD2以及在pD2水平计算的偏移比较CEC。pD2是产生半数最大效应的浓度的负常用对数(-log10EC50)。SAH后,d3组和d5组的相对局部CBF分别降至对照组CBF的63%和32%。ET -1诱导有CVS和无CVS节段的剂量依赖性收缩。在E +节段中,SAH后ET -1的E(max)无显著变化(对照组平均值[+/- SEM]为104% +/- 4%,d3组为106% +/- 4%,d5组为104% +/- 3%)。然而,与对照组相比,CEC在d3组向左显著偏移2.4倍,在d5组向左显著偏移3.6倍。SAH后S6c介导的舒张显著降低(E(max):对照组为73% +/- 11%,d3组为21% +/- 13%,d5组为13% +/- 8%),而与Ach相关的舒张无显著变化(E(max):对照组为45% +/- 7%,d3组为56% +/- 6%,d5组为43% +/- 6%)。在任何研究组的E +和E -节段中均未观察到S6c引起的显著收缩。目前的数据表明,在CVS情况下,ET(B)受体介导的脑动脉舒张功能丧失,这与内皮型一氧化氮合酶水平无关。